Kandhasamy Sarkunam

Person

Hosur, IN

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted bicyclic compounds as farnesoid X receptor modulators
- Patent number 12,227,496
- Issue date Feb 18, 2025
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted amide compounds useful as farnesoid X receptor modulators
- Patent number 12,030,835
- Issue date Jul 9, 2024
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted bicyclic compounds as farnesoid X receptor modulators
- Patent number 11,713,312
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted bicyclic compounds as farnesoid X receptor modulators
- Patent number 11,254,663
- Issue date Feb 22, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaryl substituted aminopyridine compounds
- Patent number 10,618,903
- Issue date Apr 14, 2020
- Bristol-Myers Squibb Company
- John V. Duncia
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl substituted aminopyridine compounds
- Patent number 10,202,390
- Issue date Feb 12, 2019
- Bristol-Myers Squibb Company
- John V. Duncia
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,643,999
- Issue date May 9, 2017
- Bristol-Myers Squibb Company
- Li-Qiang Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,580,463
- Issue date Feb 28, 2017
- Bristol-Myers Squibb Company
- Pulicharla Nagalakshmi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,527,885
- Issue date Dec 27, 2016
- Bristol-Myers Squibb Company
- Sheldon Hiebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 9,499,550
- Issue date Nov 22, 2016
- Bristol-Myers Squibb Company
- Li-Qiang Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl substituted nicotinamide compounds
- Patent number 9,169,252
- Issue date Oct 27, 2015
- Bristol-Myers Squibb Company
- Joseph B. Santella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 8,957,203
- Issue date Feb 17, 2015
- Bristol-Myers Squibb Company
- Sheldon Hiebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 8,691,757
- Issue date Apr 8, 2014
- Bristol-Myers Squibb Company
- Ramkumar Rajamani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20230109670
- Publication date Apr 6, 2023
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS IRAK4 INHIBITORS
- Publication number 20220281844
- Publication date Sep 8, 2022
- Bristol-Myers Squibb Company
- Saleem Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS
- Publication number 20220259205
- Publication date Aug 18, 2022
- Bristol-Myers Squibb Company
- Satheesh Kesavan Nair
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220213026
- Publication date Jul 7, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220162201
- Publication date May 26, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220135550
- Publication date May 5, 2022
- Bristol-Myers Squibb Company
- Dean A. WACKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20220081430
- Publication date Mar 17, 2022
- Bristol-Myers Squibb Company
- Dean A. Wacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
- Publication number 20210261535
- Publication date Aug 26, 2021
- Bristol-Myers Squibb Company
- Dean A. Wacker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS
- Publication number 20190292191
- Publication date Sep 26, 2019
- BRISTOL-MYERS SQUIBB COMPANY
- John V. Duncia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS
- Publication number 20180179213
- Publication date Jun 28, 2018
- BRISTROL-MYERS SQUIBB COMPANY
- John V. DUNCIA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HEPATITIS C VIRUS INHIBITORS
- Publication number 20150376233
- Publication date Dec 31, 2015
- Bristol-Myers Squibb Company
- Pulicharla Nagalakshmi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEPATITIS C VIRUS INHIBITORS
- Publication number 20150284391
- Publication date Oct 8, 2015
- Bristol-Myers Squibb Company
- Li-Qiang Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROARYL SUBSTITUTED NICOTINAMIDE COMPOUNDS
- Publication number 20150191464
- Publication date Jul 9, 2015
- Bristol-Myers Squibb Company
- Joseph B. Santella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20150125422
- Publication date May 7, 2015
- Bristol-Myers Squibb Company
- Sheldon Hiebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20140127156
- Publication date May 8, 2014
- Li-Qiang Sun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20130142754
- Publication date Jun 6, 2013
- Bristol -Myers Squibb Company
- Ramkumar Rajamani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20130115190
- Publication date May 9, 2013
- Bristol -Myers Squibb Company
- Sheldon Hiebert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kandhasamy Sarkunam

Person

Patents Grantslast 30 patents

Substituted bicyclic compounds as farnesoid X receptor modulators

Substituted amide compounds useful as farnesoid X receptor modulators

Substituted bicyclic compounds as farnesoid X receptor modulators

Substituted bicyclic compounds as farnesoid X receptor modulators

Heteroaryl substituted aminopyridine compounds

Heteroaryl substituted aminopyridine compounds

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

Heteroaryl substituted nicotinamide compounds

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

Patents Applicationslast 30 patents

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

BICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS IRAK4 INHIBITORS

TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS

SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS

SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS

HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS

HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS

HEPATITIS C VIRUS INHIBITORS

HEPATITIS C VIRUS INHIBITORS

HETEROARYL SUBSTITUTED NICOTINAMIDE COMPOUNDS

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors